[go: up one dir, main page]

TR200001187T2 - Physiologically appropriate liquid solutions and methods of use - Google Patents

Physiologically appropriate liquid solutions and methods of use

Info

Publication number
TR200001187T2
TR200001187T2 TR2000/01187T TR200001187T TR200001187T2 TR 200001187 T2 TR200001187 T2 TR 200001187T2 TR 2000/01187 T TR2000/01187 T TR 2000/01187T TR 200001187 T TR200001187 T TR 200001187T TR 200001187 T2 TR200001187 T2 TR 200001187T2
Authority
TR
Turkey
Prior art keywords
methods
physiologically appropriate
liquid solutions
appropriate liquid
physiologically
Prior art date
Application number
TR2000/01187T
Other languages
Turkish (tr)
Inventor
E. Segall Paul
Sternberg Hal
D. Waitz Harold
M. Segall Jud�Th
Original Assignee
Biotime Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotime Inc. filed Critical Biotime Inc.
Publication of TR200001187T2 publication Critical patent/TR200001187T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Fizyolojik olarak uygun sulu solüsyonlar ve kullanim metotlari anlatilmaktadir. Bahsedilen solüsyonlar sunlari içerir: elektrolitler; dinamik bir tamponlama sistemi ve onkotik ajan; klasik biyolojik tamponlari içermez. Bahsedilen solüsyon, özellikle kisinin kan hacminin en azindan bir bölümünün baska bir kanla degistirilmesi uygulamalari gibi bir çok uygulamada kullanilmasi düsünülmektedir.Physiologically appropriate aqueous solutions and methods of use are described. Said solutions include: electrolytes; a dynamic buffering system and oncotic agent; does not contain conventional biological buffers. Said solution is intended to be used in many applications, in particular at least part of the person's blood volume, such as replacing it with another blood.

TR2000/01187T 1997-10-31 1997-10-31 Physiologically appropriate liquid solutions and methods of use TR200001187T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1997/019964 WO1999022746A1 (en) 1997-10-31 1997-10-31 Physiologically acceptable aqueous solutions and methods for their use

Publications (1)

Publication Number Publication Date
TR200001187T2 true TR200001187T2 (en) 2000-08-21

Family

ID=22261994

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/01187T TR200001187T2 (en) 1997-10-31 1997-10-31 Physiologically appropriate liquid solutions and methods of use

Country Status (9)

Country Link
AU (1) AU5102698A (en)
BG (1) BG104385A (en)
CZ (1) CZ294795B6 (en)
HU (1) HUP0004094A3 (en)
SK (1) SK6282000A3 (en)
TR (1) TR200001187T2 (en)
TW (1) TW562678B (en)
UA (1) UA72449C2 (en)
WO (1) WO1999022746A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE222766T1 (en) 1994-07-01 2002-09-15 Baxter Int BIOCHEMICALLY ISOTONE PERITONEAL DIALYSIS SOLUTIONS
US9237744B2 (en) * 2004-05-26 2016-01-19 National University Corporation Kagawa University Preservative solution for cells, tissues and organs containing rare sugar and preservative method thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989010746A2 (en) * 1988-05-02 1989-11-16 Cryomedical Sciences Inc. Blood substitute
DE59101623D1 (en) * 1990-01-12 1994-06-23 Nephro Medica Pharma Infusion and dialysis solution containing bicarbonate and calcium.
CA2066374C (en) * 1991-04-19 2002-01-29 Paul E. Segall Solution for perfusing primates
ES2157260T3 (en) * 1993-06-04 2001-08-16 Biotime Inc PLASMA SIMILAR SOLUTION.
WO1996019918A1 (en) * 1994-12-28 1996-07-04 Biotime, Inc. Plasma expanders and blood substitutes

Also Published As

Publication number Publication date
HUP0004094A2 (en) 2001-03-28
WO1999022746A1 (en) 1999-05-14
CZ294795B6 (en) 2005-03-16
CZ20001531A3 (en) 2000-10-11
HUP0004094A3 (en) 2001-04-28
UA72449C2 (en) 2005-03-15
TW562678B (en) 2003-11-21
SK6282000A3 (en) 2001-02-12
AU5102698A (en) 1999-05-24
BG104385A (en) 2000-12-29

Similar Documents

Publication Publication Date Title
AR000559A1 (en) Absorbent structure with better liquid permeability and absorbent product that includes said structure
NO20023846L (en) Antiadhesive carbohydrates
DE19748290B8 (en) Solution for peritoneal dialysis
ES2130428T3 (en) INSULIN CRYSTALS ASP-B28.
CA2323627A1 (en) Latent reactive blood compatible agents
IL205242A0 (en) Substituted oxazolidinones and their use in the field of blood coagulation
DK0725628T3 (en) Thermal gel-forming drug delivery vehicles containing cellulose ethers
ES2151607T3 (en) GROWTH AND DIFFERENTIATION FACTOR 12.
AU9468998A (en) Concentrate for medical solution and use thereof
FR2782922B1 (en) COMPOSITION CONTAINING UREA AND ITS USES IN THE COSMETIC AND / OR DERMATOLOGICAL FIELD
TR200001187T2 (en) Physiologically appropriate liquid solutions and methods of use
ATE200306T1 (en) DETERMINATION OF STEROID SULFATASE
ATE353642T1 (en) USE OF HYPOESTOXIDES AS ANTIPARASITIVE AGENTS
ES2000033A6 (en) Liquid stable anthelmintic and fungicidal composition based on bithionol sulfoxide.
ES2019025A6 (en) Aqueous liquid desmopressin-CMC pharmaceutical composition.
YU25200A (en) Physiologically acceptable aqueous solution and their use
ES2060057T3 (en) AQUEOUS SOLUTIONS CONTAINING PROTEIN.
CA2389896A1 (en) Use of treosulfan for patient conditioning before bone marrow or blood stem cell transplantation
RU92015628A (en) COMPOSITION FOR DISINFECTION OF HUMAN BEARING OBJECTS
NO20002231L (en) Physiologically acceptable aqueous solutions and methods for their use
RU97109425A (en) ANTIDIABETIC COLLECTION "ROSUZ"
RU98119825A (en) GLUE COMPOSITION
RU94007074A (en) Bimetallic polymeric complex showing hemostatic and antimicrobial activity
Zhang Effect of ribavirin on acute and persistent human coronavirus infection, in vitro.
郝世奇 Cooling——a Way to Delay Death